IP Library Granted Patent US 12,080,383
Granted Patent B2
US 12,080,383 · App. 16/659,449 · Granted Sep 3, 2024

Automated nucleic acid repeat count calling methods

Inventors: A. Scott Patterson (South San Francisco, CA); Imran S. Haque (South San Francisco, CA); Eric A. Evans (South San Francisco, CA); Clement Chu (South San Francisco, CA)
Assignee: Myriad Women's Health, Inc.
G16B40/10G16B20/00G16B20/20G16B30/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,080,383
App. No.
16/659,449
Granted
Sep 3, 2024
Kind
B2
Abstract

The present disclosure relates to processes for determining the number of nucleic acid repeats in a DNA fragment comprising a nucleic acid repeat region. One example method may include receiving DNA size and abundance data generated by resolving DNA amplification products. A set of low-pass data may be generated by applying a low-pass filter to the DNA size and abundance data and a set of band-pass data may be generated by applying a band-pass filter to the DNA size and abundance data. A peak of the DNA size and abundance data representative of a number of nucleic acid repeats in the DNA may be identified based on peaks identified from the low-pass data and the band-pass data.

Claims (36)

1. A computer-implemented method for determining a number of nucleic acid repeats in a DNA comprising a nucleic acid repeat region, the method comprising:

a) receiving, by one or more processors, DNA size and abundance data of DNA amplification products generated from the DNA comprising the nucleic acid repeat region by using a primer set comprising a first primer recognizing the nucleic acid repeat region and a second primer recognizing a region outside of the nucleic acid repeat region;

b) generating, by the one or more processors, a set of sample data by sampling the DNA size and abundance data at a sampling frequency;

c) generating, by the one or more processors, a set of low-pass data by applying a low-pass filter to the set of sample data;

d) generating, by the one or more processors, a set of band-pass data by applying a band-pass filter to the set of sample data;

e) identifying, by the one or more processors, one or more peaks in the set of low-pass data;

f) identifying, by the one or more processors, one or more peaks in the set of band-pass data; and

g) identifying, by the one or more processors, a final peak representing a number of nucleic acid repeats in the nucleic acid repeat region based on the one or more peaks in the set of low-pass data and the one or more peaks in the set of band-pass data.

2. The computer-implemented method of claim 1 , further comprising resolving the DNA amplification products to generate the DNA size and abundance data prior to step a).

3. The computer-implemented method of claim 2 , wherein the resolving is carried out by capillary electrophoresis.

4. The computer-implemented method of claim 1 , further comprising converting, by the one or more processors, the DNA size and abundance data from a time domain to a base-pair length domain prior to step b).

5. The computer-implemented method of claim 4 , wherein a DNA ladder is used to convert the DNA size and abundance data from the time domain to the base-pair length domain.

6. The computer-implemented method of claim 1 , wherein the sampling frequency is equal to four samples per base-pair.

7. The computer-implemented method of claim 1 , wherein the band-pass filter has a low cutoff frequency of 2/13 multiplied by the sampling frequency and a high cutoff frequency of 2/11 multiplied by the sampling frequency.

8. The computer-implemented method of claim 1 , wherein the low-pass filter has a cutoff frequency of 1.0*10 −5 multiplied by the sampling frequency.

9. The computer-implemented method of claim 1 , wherein the low-pass filter and the band-pass filter are zero-phase finite impulse response (FIR) filters implemented using a Hamming window.

10. The computer-implemented method of claim 1 , wherein generating the set of sample data by sampling the DNA size and abundance data at the sampling frequency comprises:

generating a linear interpolation of the DNA size and abundance data; and

sampling the linear interpolation of the DNA size and abundance data at the sampling frequency.

11. The computer-implemented method of claim 1 , wherein the set of sample data comprises a signal representing a combination of a CGG series of a CGG-rich region and a full-length amplicon of the DNA comprising the CGG-rich region, the set of band-pass data comprises a signal representing the CGG series of the CGG-rich region, and the set of low-pass data comprises a signal representing the full-length amplicon of the DNA comprising the CGG-rich region.

12. The computer-implemented method of claim 1 , wherein identifying the final peak representing the number of nucleic acid repeats comprises:

removing peaks from the one or more peaks in the set of low-pass data having a width less than 4.5 base-pairs and a height less than a threshold value;

removing peaks from the one or more peaks in the set of band-pass data having a width less than 4.5 base-pairs and a height less than the threshold value;

removing peaks from the one or more peaks in the set of band-pass data having a height less than a height of an adjacent peak having a larger base-pair length;

in response to a peak of the one or more peaks in the set of low-pass data having a height less than a height of a peak of the one or more peaks in the set of band-pass data that is within 3 base-pairs of the peak of the one or more peaks in the set of low-pass data, setting a center of the peak of the one or more peaks in the set of low-pass data to a center of the peak of the one or more peaks in the set of band-pass data, and setting a boundary of the peak of the one or more peaks in the set of low-pass data to a union of the peak of the one or more peaks in the set of low-pass data and the peak of the one or more peaks in the set of band-pass data;

merging peaks of the one or more peaks in the set of low-pass data and the one or more peaks in the set of band-pass data that have base-pair lengths greater than 165 base-pairs and that are within 30 base-pairs of each other; and

merging peaks of the one or more peaks in the set of low-pass data and the one or more peaks in the set of band-pass data that are within 15 base-pairs and that are more than a factor of 2 different in height, wherein a remaining peak of the one or more peaks in the set of low-pass data is the final peak.

13. The computer-implemented method of claim 1 , wherein the DNA comprises a CGG-rich region which is a 5′-UTR of a fragile X mental retardation 1 gene (FMR1).

14. The computer-implemented method of claim 13 , wherein the DNA size and abundance data comprises a signal representing a combination of a CGG series of the FMR1 gene and a full-length amplicon of the 5′ UTR of the FMR1 gene, the set of band-pass data comprises a signal representing the CGG series of the FMR1 gene, and the set of low-pass data comprises a signal representing the full-length amplicon of the 5′ UTR of the FMR1 gene.

15. The computer-implemented method of claim 14 , further comprising determining whether an individual is a carrier for a fragile X syndrome based on a genotype of the individual, wherein a number of CGG repeats in a CGG-rich region on the 5′UTR of the FMR1 gene between 5-44 repeats is indicative of a normal allele, a number of CGG repeats in the CGG-rich region on the 5′UTR of the FMR1 gene between 45-54 repeats is indicative of an intermediate allele, a number of CGG repeats in the CGG-rich region on the 5′UTR of the FMR1 gene between 55-200 repeats is indicative of a premutation allele, and wherein a number of CGG repeats in the CGG-rich region on the 5′UTR of the FMR1 gene greater than 200 repeats is indicative of a full mutation allele.

16. The computer-implemented method of claim 1 , wherein the DNA comprises a CGG-rich region which is a 5′-UTR of a fragile X mental retardation 2 gene (FMR2).

17. The computer-implemented method of claim 1 , wherein the first primer comprises at least four CGG or CCG repeats.

18. The computer-implemented method of claim 1 , wherein the primer set further comprises a third primer recognizing a region outside of a CGG-rich region that is on an opposite side as the region recognized by the second primer.

19. The computer-implemented method of claim 1 , further comprising converting, by the one or more processors, the DNA size and abundance data from a time domain to a base-pair length domain prior to step c).

20. The computer-implemented method of claim 1 , wherein the set of sample data comprises a series of periodic peaks corresponding to successively longer CGG repeat sequences.

21. The computer-implemented method of claim 1 , wherein identifying the final peak comprises centering at least one of the one or more peaks in the set of low-pass data to the center of one of the one or more peaks in the band-pass data.

Assignments (7)
SECURITY INTEREST Recorded Aug 1, 2025
From: MYRIAD GENETICS, INC.; MYRIAD GENETIC LABORATORIES, INC.; MYRIAD WOMEN’S HEALTH, INC.; ASSUREX HEALTH, INC.; GATEWAY GENOMICS, LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP, AS ADMINISTRATIVE AGENT FOR SECURED PARTIES
Reel/Frame 072309/0932 →
RELEASE OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (064235/0032) Recorded Aug 1, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: MYRIAD GENETICS, INC.; MYRIAD WOMEN’S HEALTH, INC.; GATEWAY GENOMICS, LLC; ASSUREX HEALTH, INC.
Reel/Frame 072331/0215 →
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2023
From: JPMORGAN CHASE BANK, N.A.
To: MYRIAD GENETICS, INC.; CRESCENDO BIOSCENCE, INC.; MYRIAD RBM, INC.; MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 064239/0091 →
PATENT SECURITY AGREEMENT Recorded Jul 7, 2023
From: MYRIAD GENETICS, INC.; MYRIAD WOMEN'S HEALTH, INC.; GATEWAY GENOMICS, LLC; ASSUREX HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 064235/0032 →
SECURITY INTEREST Recorded Sep 15, 2020
From: MYRIAD WOMEN'S HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 053773/0968 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2020
From: PATTERSON, A. SCOTT; HAQUE, IMRAN S.; EVANS, ERIC A.; CHU, CLEMENT
To: COUNSYL, INC.
Reel/Frame 052992/0810 →
CHANGE OF NAME Recorded Jun 19, 2020
From: COUNSYL, INC.
To: MYRIAD WOMEN'S HEALTH, INC.
Reel/Frame 052993/0530 →